Are lower MRPs on cancer drugs translating into affordable care?

National Pharmaceutical Pricing Authority (NPPA) has capped trade margins at 30% for 137 non-scheduled anti-cancer drugs, reducing the price of nearly 900…

1 sources · 1 articles · updated 2026-11-05 19:39 UTC · opinion

Coverage

1. Are lower MRPs on cancer drugs translating into affordable care?

   The Hindu · 2026-11-05 19:39 UTC

   National Pharmaceutical Pricing Authority (NPPA) has capped trade margins at 30% for 137 non-scheduled anti-cancer drugs, reducing the price of nearly 900 cancer medicine brands by up to 70%-93%. However, for comprehensive cancer care in India, price regulation might not be enough.

   Summary on nerom.app